Semaglutide 5mg - 4 Pack99% Pure
GLP-1 Agonists

Semaglutide 5mg - 4 Pack

A cost-effective bulk research package containing four vials of high-purity Semaglutide, ideal for longitudinal studies, dose-response experiments, and high-throughput metabolic research protocols.

Molecular Weight

4113.58 g/mol

Sequence

Modified GLP-1 (31 amino acids) with C18 fatty acid

$464.99
1
Lab Tested
99%+ Purity
Fast Shipping
Molecular Formula

C187H291N45O59

Molecular Weight

4113.58 g/mol

Purity

99%

CAS Number

910463-68-2

Half Life

7 days

Storage

2-8°C

Administration

subcutaneous

Research Status

approved

View on PubChem

Description

The Semaglutide 5mg 4-Pack provides researchers with an economical solution for extended study protocols and larger-scale investigations. Each package contains four individually sealed vials of pharmaceutical-grade Semaglutide, the potent GLP-1 receptor agonist renowned for its stability and consistent research outcomes in metabolic studies. This bulk format is specifically designed for laboratories conducting longitudinal research, dose-response characterization, or comparative studies requiring consistent compound availability. Whether investigating glucose homeostasis, appetite regulation mechanisms, or cardiovascular biomarkers, this 4-pack ensures supply continuity and batch consistency across your entire research timeline. Package Contents 4 × 5mg vials (20mg total) ≥98% purity verified by HPLC Lot-matched Certificate of Analysis Bulk pricing saves ~15% vs individual units Exclusively for laboratory research applications.

Research

FDA-approved for: - Type 2 diabetes (Ozempic) - Chronic weight management (Wegovy) - Cardiovascular risk reduction - NASH research - Alzheimer's prevention studies - Addiction research - PCOS management

Mechanism

GLP-1 receptor agonist: 1. Enhances insulin secretion (glucose-dependent) 2. Suppresses glucagon secretion 3. Slows gastric emptying 4. Reduces appetite via hypothalamus 5. Improves beta cell function 6. Cardiovascular protection 7. Neuroprotective effects

Benefits

Significant weight loss (15-20%) Improved glycemic control Cardiovascular protection Reduced inflammation Potential neuroprotection Improved lipid profiles Blood pressure reduction NASH improvement

Dosage

FDA-approved dosing: - Starting: 0.25mg weekly for 4 weeks - Titration: 0.5mg weekly for 4 weeks - Maintenance: 1mg-2.4mg weekly - Weight loss: Up to 2.4mg weekly - Inject same day each week

Safety

Common side effects: - Nausea (most common) - Vomiting - Diarrhea - Constipation - Abdominal pain - Decreased appetite - Fatigue - Rare: pancreatitis, gallbladder issues
Helix AI
HELIXOnline